1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Custom Antibody Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Custom Antibody Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Custom Antibody Market Regional Analysis
6.2 North America Custom Antibody Market Revenue 2019-2028 (US$ Million)
6.3 North America Custom Antibody Market Forecast Analysis
7. North America Custom Antibody Market Analysis – by Service
7.1 Antibody Development
- 7.1.1 Overview
- 7.1.2 Antibody Development: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Antibody Production and Purification
- 7.2.1 Overview
- 7.2.2 Antibody Production and Purification: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Antibody Fragmentation and Labelling
- 7.3.1 Overview
- 7.3.2 Antibody Fragmentation and Labelling: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Custom Antibody Market Analysis – by Type
8.1 Monoclonal Antibodies
- 8.1.1 Overview
- 8.1.2 Monoclonal Antibodies: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Polyclonal Antibodies
- 8.2.1 Overview
- 8.2.2 Polyclonal Antibodies: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Other Custom Antibodies
- 8.3.1 Overview
- 8.3.2 Other Custom Antibodies: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Custom Antibody Market Analysis – by Source
9.1 Mice
- 9.1.1 Overview
- 9.1.2 Mice: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Rabbits
- 9.2.1 Overview
- 9.2.2 Rabbits: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Custom Antibody Market Analysis – by Research Area
10.1 Oncology
- 10.1.1 Overview
- 10.1.2 Oncology: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Immunology
- 10.2.1 Overview
- 10.2.2 Immunology: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Stem Cells
- 10.3.1 Overview
- 10.3.2 Stem Cells: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.4 Infectious Diseases
- 10.4.1 Overview
- 10.4.2 Infectious Diseases: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.5 Neurobiology
- 10.5.1 Overview
- 10.5.2 Neurobiology: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.6 Cardiovascular Diseases
- 10.6.1 Overview
- 10.6.2 Cardiovascular Diseases: North America Custom Antibody Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. North America Custom Antibody Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Custom Antibody Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 11.2.1.1 North America Custom Antibody Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Custom Antibody Market Breakdown, by Service
- 11.2.1.1.2 US: North America Custom Antibody Market Breakdown, by Type
- 11.2.1.1.3 US: North America Custom Antibody Market Breakdown, by Source
- 11.2.1.1.4 US: North America Custom Antibody Market Breakdown, by Research Area
- 11.2.1.2 Canada:
North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Custom Antibody Market Breakdown, by Service
- 11.2.1.2.2 Canada: North America Custom Antibody Market Breakdown, by Type
- 11.2.1.2.3 Canada: North America Custom Antibody Market Breakdown, by Source
- 11.2.1.2.4 Canada: North America Custom Antibody Market Breakdown, by Research Area
- 11.2.1.3 Mexico :
North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Custom Antibody Market Breakdown, by Service
- 11.2.1.3.2 Mexico : North America Custom Antibody Market Breakdown, by Type
- 11.2.1.3.3 Mexico : North America Custom Antibody Market Breakdown, by Source
- 11.2.1.3.4 Mexico : North America Custom Antibody Market Breakdown, by Research Area
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Bio-Rad Laboratories Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Merck KGAA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Abcam
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Genscript
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Rockland Immunochemicals, Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Promab
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Biolegend, Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Agilent Technologies, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Cell Signaling Technology, Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations